UCI President Supports Selective Night Testing After Tour de France Doping Debate

What happened:

Watch the highlights:

UCI president David Lappartient has backed the use of night-time drug testing during races in exceptional cases, according to The Guardian. Speaking at the start of stage two of the Tour de France Femmes in Aigle, Lappartient said cycling will “always” face suspicion because of its past, while also insisting that this year’s men’s Tour de France was clean.

The key point is not that night testing will become routine. Lappartient’s position, as reported, is more selective: he supports it when circumstances justify the intrusion. That matters because night testing sits in a difficult space for endurance sports. It can strengthen deterrence and close perceived loopholes, but it also raises questions about athlete recovery, proportionality and how anti-doping bodies decide when a case is exceptional.

Why it matters:

The Tour de France remains the sport’s most visible competitive stage, so any anti-doping controversy around it carries consequences beyond one race. Lappartient’s comments are partly a defense of the 2026 men’s Tour and partly an acknowledgement that clean results alone do not erase public doubt. In cycling, the credibility contest is continuous: race performances are judged not only by tactics, climbing, time gaps and team strength, but also by how convincing the testing framework appears around them.

Lappartient pointed to the International Testing Agency’s public process as evidence. He said the ITA does not issue press releases for negative results, only for positives, and that because no positive-test announcement appeared during the Tour, “it seems there was nothing in the Tour.” That is a careful form of reassurance rather than a full public audit. The source confirms the absence of positive announcements; it does not provide a detailed testing breakdown, timing log, sample count or later-stage laboratory status.

Tournament impact:

For the Tour de France and Tour de France Femmes, this keeps anti-doping governance close to the sporting product. Fans want to know whether a result can be trusted, especially when performances become dominant or controversial. Selective night testing would be a signal that organizers and regulators are willing to increase scrutiny when suspicion or intelligence warrants it, but the policy’s legitimacy will depend on consistency and transparency.

What to watch:

The next practical question is how “exceptional cases” are defined. If that threshold is vague, riders and teams may see the system as unpredictable. If it is too narrow, critics may argue the policy is mostly symbolic. The strongest version would likely require clear criteria, independent oversight and post-race reporting that explains the scale of testing without compromising investigations.

Confidence:

Confirmed by the source: Lappartient supported selective night-time testing, said cycling will always face suspicion because of its past, and argued that no ITA positive-test announcement indicated no positive case from the men’s Tour. Still needing follow-up: exact testing numbers, whether any policy change is imminent, and how exceptional night-testing cases would be selected.